Literature DB >> 33411700

Assessment of Day-7 Postexposure Testing of Asymptomatic Contacts of COVID-19 Patients to Evaluate Early Release from Quarantine - Vermont, May-November 2020.

Amanda Jones1, Veronica Fialkowski1, Lauren Prinzing1, Jeffrey Trites1, Patsy Kelso1, Mark Levine1.   

Abstract

On May 8, 2020, the Vermont Department of Health (VDH) issued a Health Update* recommending shortening the duration of quarantine for persons exposed to SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). Exposed persons who were in quarantine could be tested by polymerase chain reaction (PCR) on or after quarantine day 7. Those who had remained asymptomatic throughout quarantine and who received a negative SARS-CoV-2 PCR test result on or after day 7 could end quarantine. This policy was based on a report suggesting that symptom onset occurs within this time frame in approximately three quarters of COVID-19 cases (1) and on consultation of the Vermont Health Commissioner with the U.S. Surgeon General. VDH implemented this policy to minimize restrictions on state residents, recognizing that some reduction could occur in the prevention benefit of quarantine to contain the spread of SARS-CoV-2. State-run SARS-CoV-2 testing sites were made available to increase access to no-cost testing and facilitate implementation of this policy. During August 1-December 1, among persons seeking testing at a VDH SARS-CoV-2 testing site, 36% stated that their reason for seeking testing was to end quarantine early (VDH, unpublished data, December 7, 2020), indicating that persons were aware of and following the policy and using the testing services provided. To assess the effectiveness of this policy, VDH analyzed testing data for contacts of persons with a COVID-19 diagnosis. During May 8-November 16, VDH identified 8,798 exposed contacts of COVID-19 patients; 3,983 (45%) had sought testing within 14 days of their exposure, with day 0 defined as the date of last exposure noted in the case investigation record. Among these persons, 2,200 (55%) who received testing on days 7-10 were included in this analysis; 977 (44.9%) of these contacts had a specimen collected for testing on day 7. Among these, 34 (3%) had test results that were positive, 940 (96%) had results that were negative, and three (<1%) had results that were indeterminate (Table). Among the 34 contacts who received a positive SARS-CoV-2 PCR test result on day 7 after exposure, 12 (35%) were asymptomatic. The remaining 22 contacts with positive test results were symptomatic at the time of testing; approximately one half had developed symptoms on days 4-7 after exposure. Among the 940 contacts who received negative test results on specimens collected on day 7 after exposure, 154 (16%) had a subsequent test within the next 7 days (i.e., days 8-14); among these, 152 (99%) had tests that remained negative, and two (1%) had results that were indeterminate.

Entities:  

Mesh:

Year:  2021        PMID: 33411700      PMCID: PMC7790157          DOI: 10.15585/mmwr.mm7001a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  1 in total

1.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.

Authors:  Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

  1 in total
  5 in total

1.  Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.

Authors:  Diana Buitrago-Garcia; Aziz Mert Ipekci; Leonie Heron; Hira Imeri; Lucia Araujo-Chaveron; Ingrid Arevalo-Rodriguez; Agustín Ciapponi; Muge Cevik; Anthony Hauser; Muhammad Irfanul Alam; Kaspar Meili; Eric A Meyerowitz; Nirmala Prajapati; Xueting Qiu; Aaron Richterman; William Gildardo Robles-Rodriguez; Shabnam Thapa; Ivan Zhelyazkov; Georgia Salanti; Nicola Low
Journal:  PLoS Med       Date:  2022-05-26       Impact factor: 11.613

2.  COVID-19 Case Investigation and Contact Tracing in the US, 2020.

Authors:  R Ryan Lash; Patrick K Moonan; Brittany L Byers; Robert A Bonacci; Kimberly E Bonner; Matthew Donahue; Catherine V Donovan; Heather N Grome; Julia M Janssen; Reed Magleby; Heather P McLaughlin; James S Miller; Caroline Q Pratt; Jonathan Steinberg; Kate Varela; Greta L Anschuetz; Paul R Cieslak; Veronica Fialkowski; Aaron T Fleischauer; Clay Goddard; Sara Jo Johnson; Michelle Morris; Jill Moses; Allison Newman; Lauren Prinzing; Alana C Sulka; Puthiery Va; Matthew Willis; John E Oeltmann
Journal:  JAMA Netw Open       Date:  2021-06-01

3.  The Efficacy of Health Surveys and Polymerase Chain Reaction Tests Prior to Judo Tournaments During the COVID-19 Pandemic.

Authors:  Naoki Sakuyama; Yasuo Mikami; Akira Ikumi; Naohisa Fujita; Shinji Nagahiro
Journal:  Cureus       Date:  2022-01-02

4.  Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel.

Authors:  Vishal P Shah; Laura E Breeher; Julie M Alleckson; David G Rivers; Zhen Wang; Emily R Stratton; Wigdan Farah; Caitlin M Hainy; Melanie D Swift
Journal:  Infect Control Hosp Epidemiol       Date:  2022-01-06       Impact factor: 3.254

5.  Missing science: A scoping study of COVID-19 epidemiological data in the United States.

Authors:  Rajiv Bhatia; Isabella Sledge; Stefan Baral
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.